| Literature DB >> 33657088 |
Blagovesta Popova1, Dan Wang1, Christina Pätz1, Dagmar Akkermann1, Diana F Lázaro2, Dajana Galka1, Miriam Kolog Gulko1, Markus T Bohnsack3, Wiebke Möbius4, Katherine E Bohnsack3, Tiago F Outeiro2,5, Gerhard H Braus1.
Abstract
Parkinson's disease is a neurodegenerative disorder associated with misfolding and aggregation of α-synuclein as a hallmark protein. Two yeast strain collections comprising conditional alleles of essential genes were screened for the ability of each allele to reduce or improve yeast growth upon α-synuclein expression. The resulting 98 novel modulators of α-synuclein toxicity clustered in several major categories including transcription, rRNA processing and ribosome biogenesis, RNA metabolism and protein degradation. Furthermore, expression of α-synuclein caused alterations in pre-rRNA transcript levels in yeast and in human cells. We identified the nucleolar DEAD-box helicase Dbp4 as a prominent modulator of α-synuclein toxicity. Downregulation of DBP4 rescued cells from α-synuclein toxicity, whereas overexpression led to a synthetic lethal phenotype. We discovered that α-synuclein interacts with Dbp4 or its human ortholog DDX10, sequesters the protein outside the nucleolus in yeast and in human cells, and stabilizes a fraction of α-synuclein oligomeric species. These findings provide a novel link between nucleolar processes and α-synuclein mediated toxicity with DDX10 emerging as a promising drug target.Entities:
Mesh:
Substances:
Year: 2021 PMID: 33657088 PMCID: PMC7928443 DOI: 10.1371/journal.pgen.1009407
Source DB: PubMed Journal: PLoS Genet ISSN: 1553-7390 Impact factor: 5.917